Usefulness of aqueous and vitreous humor analysis in infectious uveitis

Carregando...
Imagem de Miniatura
Citações na Scopus
12
Tipo de produção
article
Data de publicação
2020
Título da Revista
ISSN da Revista
Título do Volume
Editora
HOSPITAL CLINICAS, UNIV SAO PAULO
Autores
SANTOSGH, Helen Nazareth Veloso dos
FERRACIOLI-ODA, Eduardo
OTANI, Camila Sayuri Vicentini
TANAKA, Tatiana
SILVA, Luciane de Carvalho Sarahyba da
LOPES, Guilherme de Oliveira
HIRATA, Carlos Eduardo
YAMAMOTO, Joyce Hisae
Citação
CLINICS, v.75, article ID e1498, 6p, 2020
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
OBJECTIVE: To evaluate the role of intraocular fluid analysis as a diagnostic aid for uveitis. METHODS: Twenty-eight samples (27 patients including 3 HIV-infected patients) with active (n=24) or non-active (n=4) uveitis were submitted to aqueous (AH; n=12) or vitreous humor (VH) analysis (n=16). All samples were analyzed by quantitative PCR for herpes simplex virus (HSV), varicella zoster virus (VZV), cytomegalovirus (CMV), Epstein-Barr virus (EBV) and Toxoplasma gondii. RESULTS: The positivity of the PCR in AH was 41.7% (5/12), with 50% (2/4) in immunocompetent and 67% (2/3) in HIV+ patients. The positivity of the PCR in VH was 31.2% (5/16), with 13% (1/8) in immunocompetent and 50% (4/8) in immunosuppressed HIV negative patients. The analysis was a determinant in the diagnostic definition in 58% of HA and 50% of VH. CONCLUSION: Even in posterior uveitis, initial AH analysis may be helpful. A careful formulation of possible clinical diagnosis seems to increase the chance of intraocular sample analysis being meaningful.
Palavras-chave
Polymerase Chain Reaction, Infectious Disease, Uveitis, Aqueous Humor, Vitreous Humor
Referências
  1. Al Dhibi HA, 2017, OCUL IMMUNOL INFLAMM, V25, P388, DOI 10.3109/09273948.2015.1133836
  2. Calvo CM, 2017, OCUL IMMUNOL INFLAMM, V25, P246, DOI 10.3109/09273948.2015.1115081
  3. Cassaing S, 2006, J CLIN MICROBIOL, V44, P720, DOI 10.1128/JCM.44.3.720-724.2006
  4. Chronopoulos A, 2016, BMC OPHTHALMOL, V16, DOI 10.1186/s12886-016-0369-z
  5. De Groot-Mijnes JDF, 2006, AM J OPHTHALMOL, V141, P313, DOI 10.1016/j.ajo.2005.09.017
  6. Demirag A, 1998, TRANSPLANT P, V30, P3166, DOI 10.1016/S0041-1345(98)00979-8
  7. dos Santos FF, 2015, ARQ BRAS OFTALMOL, V78, P356, DOI 10.5935/0004-2749.20150094
  8. dos Santos FF, 2011, ARQ BRAS OFTALMOL, V74, P258, DOI 10.1590/S0004-27492011000400006
  9. Elyashiv Sivan M, 2020, Retina, V40, P567, DOI 10.1097/IAE.0000000000002423
  10. Errera MH, 2013, OCUL IMMUNOL INFLAMM, V21, P46, DOI 10.3109/09273948.2012.730653
  11. Fernandez DG, 2017, OCUL IMMUNOL INFLAMM, V25, P382, DOI 10.3109/09273948.2015.1132741
  12. Gouveia Enéias Bezerra, 2004, Arq. Bras. Oftalmol., V67, P139, DOI 10.1590/S0004-27492004000100025
  13. Harper TW, 2009, AM J OPHTHALMOL, V147, P140, DOI 10.1016/j.ajo.2008.07.043
  14. Hillenkamp J, 2009, OPHTHALMOLOGY, V116, P1971, DOI 10.1016/j.ophtha.2009.03.029
  15. Jabs DA, 2005, AM J OPHTHALMOL, V140, P509, DOI 10.1016/j.ajo.2005.03.057
  16. Jabs DA, 2013, AM J OPHTHALMOL, V156, P228, DOI 10.1016/j.ajo.2013.03.027
  17. Jeroudi Abdallah, 2014, Int Ophthalmol Clin, V54, P173, DOI 10.1097/IIO.0000000000000017
  18. Kongyai N, 2012, JPN J OPHTHALMOL, V56, P390, DOI 10.1007/s10384-012-0144-5
  19. Kumar A, 2017, DIAGN MICR INFEC DIS, V89, P191, DOI 10.1016/j.diagmicrobio.2017.08.002
  20. Lee RW, 2014, SEMIN IMMUNOPATHOL, V36, P581, DOI 10.1007/s00281-014-0433-9
  21. Machida U, 2000, J CLIN MICROBIOL, V38, P2536, DOI 10.1128/JCM.38.7.2536-2542.2000
  22. Mochizuki M, 2017, JPN J OPHTHALMOL, V61, P1, DOI 10.1007/s10384-016-0474-9
  23. Oahalou A, 2014, RETINA-J RET VIT DIS, V34, P108, DOI 10.1097/IAE.0b013e31828e6985
  24. Ohguro N, 2012, JPN J OPHTHALMOL, V56, P432, DOI 10.1007/s10384-012-0158-z
  25. Oruc S, 2003, OCUL IMMUNOL INFLAMM, V11, P287, DOI 10.1076/ocii.11.4.287.18270
  26. da Silva LMP, 2013, ARQ BRAS OFTALMOL, V76, P366, DOI 10.1590/S0004-27492013000600010
  27. Rothova A, 1996, BRIT J OPHTHALMOL, V80, P332, DOI 10.1136/bjo.80.4.332
  28. Rothova A, 2008, OPHTHALMOLOGY, V115, P306, DOI 10.1016/j.ophtha.2007.05.014
  29. Roy R, 2014, OCUL IMMUNOL INFLAMM, V22, P170, DOI 10.3109/09273948.2013.819928
  30. Sato T, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000011572
  31. Scheepers MA, 2013, SCI WORLD J, DOI 10.1155/2013/545149
  32. Schmutzhard J, 2004, J CLIN VIROL, V29, P120, DOI 10.1016/S1386-6532(03)00113-6
  33. Siak J, 2017, OCUL IMMUNOL INFLAMM, V25, pS81, DOI 10.1080/09273948.2016.1188968
  34. Steeples LR, 2016, BRIT J OPHTHALMOL, V100, P200, DOI 10.1136/bjophthalmol-2015-306801
  35. SuttorpSchulten MSA, 1996, BRIT J OPHTHALMOL, V80, P844, DOI 10.1136/bjo.80.9.844
  36. Talabani H, 2009, J CLIN MICROBIOL, V47, P2131, DOI 10.1128/JCM.00128-09
  37. Van Gelder RN, 2003, RETINA-J RET VIT DIS, V23, P445, DOI 10.1097/00006982-200308000-00001
  38. Venkatesh P, 2016, INT OPHTHALMOL, V36, P365, DOI 10.1007/s10792-015-0128-9